Commonwealth Games 200 metres bronze medalist Jason Livermore was this morning handed a two year ban for violating the rules of Jamaica anti-doping commission (JADCO).

The sanction is retroactive to February this year when Livermore was notified of a 2016 positive tests for the banned drugs Clomifhene and Mestorolone . The (metabolites) of both substances were found in his urine samples in December 2016.

Chairman Kent gammon said that based on evidence presented at a hearing last month, the panel did not believe Livermore intended to take the substances to enhance his athletic performance but was negligent in applying for therapeutic use exception.

The 29-year-old sprinter had testified at the hearing he had declared two medications which contained the banned substances.

The verdict was handed down by judge, Kent gammon, chairman of the independent anti-doping disciplinary panel.

As such Livermore will not be eligible to compete until February 2019.

Clomifhene and Mestorolone are linked to the enhancement of low sperm quality in male and is also a medication used to treat infertility in women who do not ovulate.

Livermore revealed he was taking the medications from November 29, 2016 to treat a “life threatening” situation.